HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 97.99 Billion | 99.59 Billion | 53.49 Billion | 91.79 Billion | 114.01 Billion | 102.47 Billion |
| Cost of Revenue | 98.73 Billion | 104.15 Billion | 59.78 Billion | 90.37 Billion | 107.9 Billion | 98.04 Billion |
| Gross Profit | -748.57 Million | -4.56 Billion | -6.29 Billion | 1.42 Billion | 6.11 Billion | 4.42 Billion |
| Operating Expenses | 23.78 Billion | 15.38 Billion | 12.03 Billion | 9.43 Billion | 11.48 Billion | 12.19 Billion |
| Selling, General and Administrative Expenses | 16.55 Billion | 10.84 Billion | 8.07 Billion | 7.79 Billion | 9.9 Billion | 10.79 Billion |
| Research and Development Expenses | 5.45 Billion | 4.34 Billion | 3.84 Billion | 1.43 Billion | 1.42 Billion | 1.32 Billion |
| Other Expenses | - | -192.67 Million | -113.46 Million | -211.73 Million | -157.62 Million | -77.34 Million |
| Cost and Expenses | 122.52 Billion | 119.54 Billion | 71.82 Billion | 99.81 Billion | 119.39 Billion | 110.23 Billion |
| Operating Income | -24.53 Billion | -19.94 Billion | -18.32 Billion | -8.01 Billion | -5.37 Billion | -7.76 Billion |
| Interest Expense | 21.65 Billion | 9.87 Billion | 1.25 Billion | 2.1 Billion | 7.63 Billion | 8.8 Billion |
| Income Tax Expense | -590.06 Million | -6.47 Billion | -4.33 Billion | -654.24 Million | 1 Billion | 28.49 Million |
| Earnings before Tax | -6.5 Billion | -63.44 Billion | -57.19 Billion | -48.87 Billion | 8.56 Billion | -18.42 Billion |
| Net Income | -5.98 Billion | -54.27 Billion | -49.15 Billion | -55.79 Billion | 7.52 Billion | -18.19 Billion |
| Earnings Per Share Basic | -54.79 | -537.56 | -494.76 | -563.59 | 76.34 | -285.30 |
| Earnings Per Share Diluted | -54.79 | -537.56 | -494.76 | -563.59 | 76.34 | -285.30 |
| Weighted Average Shares Outstanding | 109.19 Million | 100.97 Million | 99.34 Million | 99 Million | 98.5 Million | 63.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 109.19 Million | 100.97 Million | 99.34 Million | 99 Million | 98.5 Million | 63.76 Million |
| Gross Margin | -0.01 | -0.05 | -0.12 | 0.02 | 0.05 | 0.04 |
| EBIT Margin | -0.18 | -0.15 | -0.30 | -0.07 | -0.03 | -0.07 |
| Profit Margin | -0.06 | -0.55 | -0.92 | -0.61 | 0.07 | -0.18 |
| EBITDA | -17.79 Billion | -48.59 Billion | -53.87 Billion | -45.2 Billion | 18.09 Billion | -9.27 Billion |
| Earnings Before Tax Margin | -0.25 | -0.20 | -0.34 | -0.09 | -0.05 | -0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.58 Billion | 23.89 Billion | 23.55 Billion | 97.99 Billion | 21.84 Billion | 21.42 Billion |
| Cost of Revenue | 24.57 Billion | 24.13 Billion | 25.48 Billion | 101.46 Billion | 23.43 Billion | 23.08 Billion |
| Gross Profit | -991.43 Million | -243.46 Million | -1.93 Billion | -3.47 Billion | -1.58 Billion | -1.65 Billion |
| Operating Expenses | 5.25 Billion | 5.4 Billion | 6.72 Billion | 22.03 Billion | 4.83 Billion | 5 Billion |
| Selling, General and Administrative Expenses | 3.92 Billion | 4.12 Billion | 4.35 Billion | - | 3.78 Billion | 3.74 Billion |
| Research and Development Expenses | 1.23 Billion | 1.18 Billion | 2.37 Billion | - | 938.12 Million | 1.25 Billion |
| Other Expenses | -90.8 Million | -96.01 Million | 4.09 Billion | -27.68 Million | -111.07 Million | 77.84 Million |
| Cost and Expenses | 29.82 Billion | 29.54 Billion | 32.2 Billion | 123.5 Billion | 28.26 Billion | 28.08 Billion |
| Operating Income | -6.24 Billion | -5.64 Billion | -8.65 Billion | -25.51 Billion | -6.42 Billion | -6.65 Billion |
| Interest Expense | 4.89 Billion | 5.87 Billion | 10.87 Billion | 21.65 Billion | 7.01 Billion | 5.32 Billion |
| Income Tax Expense | 882.16 Million | -384.17 Million | 2.63 Billion | -590.06 Million | -1.14 Billion | -1.06 Billion |
| Earnings before Tax | -143.87 Billion | 145.82 Billion | 8.46 Billion | -5.29 Billion | -16.46 Billion | -9.79 Billion |
| Net Income | -144.43 Billion | 145.09 Billion | 6.45 Billion | -5.98 Billion | -16.31 Billion | -9.78 Billion |
| Earnings Per Share Basic | -1333.00 | 1358.14 | 63.39 | - | -160.29 | -96.10 |
| Earnings Per Share Diluted | -1333.00 | 1358.14 | 63.39 | - | -160.29 | -96.10 |
| Weighted Average Shares Outstanding | 108.35 Million | 106.83 Million | 101.78 Million | 101.78 Million | 101.78 Million | 101.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 108.35 Million | 106.83 Million | 101.78 Million | 101.78 Million | 101.78 Million | 101.76 Million |
| Gross Margin | -0.04 | -0.01 | -0.08 | -0.04 | -0.07 | -0.08 |
| EBIT Margin | -0.20 | -0.17 | -0.29 | - | -0.21 | -0.21 |
| Profit Margin | -6.13 | 6.07 | 0.27 | -0.06 | -0.75 | -0.46 |
| EBITDA | -4.75 Billion | -4.04 Billion | -6.9 Billion | - | -4.49 Billion | -4.6 Billion |
| Earnings Before Tax Margin | -0.26 | -0.24 | -0.37 | -0.26 | -0.29 | -0.31 |
1539
BPO-PE
FTT
5274
8215
TOH